2025-08-26 - Analysis Report
Okay, here is an analysis of Natera Inc. (NTRA) based on the provided data, formatted in a report style with English and including both numerical summaries and analytical insights.

## Natera Inc. (NTRA) Stock Analysis

**Ticker:** NTRA
**Company Description:** Natera Inc. is a diagnostics company specializing in genetic testing.

### 1. Performance vs. S&P 500 (VOO)

**Key Metrics:**

*   **NTRA Cumulative Return:** 151.71%
*   **VOO Cumulative Return:** 38.06%
*   **Absolute Divergence:** 49.4
    *   Max Divergence: 631.9
    *   Min Divergence: -39.3
*   **Relative Divergence:** 13.2

**Analysis:**

NTRA has significantly outperformed the S&P 500 (VOO) over the period examined. The current divergence of 49.4 indicates a substantial outperformance. A relative divergence of 13.2 suggests that the current outperformance is near the lower end of its historical range compared to VOO. This doesn't necessarily mean the outperformance will end, but it does provide context.

**Alpha/Beta Analysis:**

| Year       |   CAGR |   MDD |   Alpha |   Beta |   Cap(B) |
|------------|-------:|------:|--------:|-------:|---------:|
| 2015-2017  |   -6   |  62.4 |   -6    |    1   |      1.2 |
| 2016-2018  |   29   |  80.1 |   29    |    1   |      1.9 |
| 2017-2019  |  159   |  80.1 |  159    |    1   |      4.6 |
| 2018-2020  |  530   |  80.1 |  530    |    1   |     13.7 |
| 2019-2021  |  355   |  62.9 |  355    |   -0   |     12.8 |
| 2020-2022  | -119   |  62.9 | -108    |   -0.1 |      5.5 |
| 2021-2023  | -482   |  69.9 | -492    |   -0   |      8.6 |
| 2022-2024  |  -75   |  70.6 | -105    |   -0   |     21.7 |
| 2023-2025  |  100   |  76.1 |   56    |    0   |     22.3 |

**Analysis:**

*   **CAGR:** NTRA has experienced both periods of substantial growth and significant decline.
*   **MDD:** The Maximum Drawdown figures are quite high, indicating substantial volatility.
*   **Alpha:**  NTRA's alpha generally reflects its CAGR, showing significant excess returns (positive alpha) in some periods and considerable underperformance (negative alpha) in others.
*   **Beta:** The beta fluctuates but is relatively close to zero. This suggests NTRA's returns are relatively uncorrelated with market volatility, though historical data has shown otherwise

### 2. Recent Stock Price Movement

**Key Metrics:**

*   **Current Price:** 162.47
*   **Previous Close:** 165.6
*   **Change:** -1.89
*   **5-day Moving Average:** 162.156
*   **20-day Moving Average:** 151.0415
*   **60-day Moving Average:** 156.2277

**Analysis:**

The stock price decreased slightly from the previous close. The 5-day moving average is above the 20-day and 60-day moving averages, which suggests a short-term upward trend. However, the recent price decrease indicates a possible pullback.

### 3. Market Risk Indicators and Expected Return

**Key Metrics:**

*   **Market Risk Indicator (MRI):** 0.3237 (Low Risk)
*   **RSI:** 76.226 (Overbought)
*   **PPO:** 1.1841
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.32)
*   **20-day Relative Divergence Change:** 1.0 (Positive - Short-term increase)
*   **Expected Return:** 108.9% (vs. S&P 500 over 2+ years)

**Analysis:**

*   **MRI:** The MRI is in the low-risk range, suggesting favorable market conditions for NTRA.
*   **RSI:** An RSI of 76.226 indicates that the stock is currently overbought, which could precede a price correction.
*   **PPO:** A positive PPO indicates an upward trend.
*   **Hybrid Signal:** The hybrid signal suggests a strong buy recommendation.
*   **Relative Divergence Change:** The positive change in relative divergence supports the short-term upward trend.
*   **Expected Return:** The high expected return (108.9%) suggests potential for significant outperformance compared to the S&P 500 over the long term, assuming consistent investment.
*   **Change:** The change of -1.89 from the previous close, while not drastic, should be monitored as it could indicate the start of a downward trend, especially given the overbought RSI.

### 4. Recent News & Significant Events

*   **[2025-08-25]:** Major business developments, regulatory changes, or market events reported.
*   **[2025-08-22]:** Analysts discussing NTRA's recent performance and outlook within industry trends.
*   **[2025-08-24]:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-08-26]:** Market experts highlighting both risks and opportunities.

**Analysis:**

Recent news points to significant activity around NTRA, including business developments, analyst discussions, and stock volatility. Investors should monitor these developments closely.

### 5. Recent Earnings Analysis

| 날짜       |    EPS | 매출     |
|:-----------|-------:|:---------|
| 2025-08-08 |   -0.74 | 0.55 B$ |
| 2025-05-09 |   -0.5  | 0.50 B$ |
| 2024-11-12 |   -0.26 | 0.44 B$ |
| 2024-08-09 |   -0.3  | 0.41 B$ |
| 2025-08-08 |   -0.3  | 0.41 B$ |

**Analysis:**

*   NTRA consistently reported negative EPS (Earnings Per Share).
*   Revenue has generally increased over the periods shown.
*   The most recent quarter (2025-08-08) shows the highest revenue ($0.55B) but also the largest EPS loss (-$0.74). This could indicate increased spending to drive growth.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      |   Revenue |   Profit Margin |
|:-------------|----------:|----------------:|
| 2025-06-30   |    $0.55B |          63.41% |
| 2025-03-31   |    $0.50B |          63.12% |
| 2024-12-31   |    $0.48B |          62.94% |
| 2024-09-30   |    $0.44B |          61.79% |
| 2024-06-30   |    $0.41B |          58.83% |

**Capital and Profitability:**

| Quarter      |   Equity |      ROE |
|:-------------|---------:|---------:|
| 2025-06-30   |  $1.25B |  -8.10% |
| 2025-03-31   |  $1.24B |  -5.40% |
| 2024-12-31   |  $1.20B |  -4.50% |
| 2024-09-30   |  $0.88B |  -3.60% |
| 2024-06-30   |  $0.84B |  -4.48% |

**Analysis:**

*   **Revenue:** Revenue has been steadily increasing, demonstrating business growth.
*   **Profit Margin:** Profit margins are high and improving, suggesting operational efficiency.
*   **Equity:** Equity has grown significantly.
*   **ROE:**  Return on Equity (ROE) is negative, consistent with the negative EPS. While improving, it indicates that the company is not yet generating profits from its equity.

### 7. 종합적인 분석 (Overall Analysis)

Natera Inc. (NTRA) presents a mixed picture:

*   **Strengths:** Significant historical outperformance relative to the S&P 500, high revenue growth, increasing profit margins, strong buy signal based on hybrid indicators, and high expected return (though long-term).

*   **Weaknesses:** High volatility (MDD), negative EPS and ROE, recent overbought RSI suggesting potential pullback, and the reliance on sustained high growth to justify the current valuation.

*   **Considerations:** Recent news and market events indicate that the stock is subject to external influences. Close monitoring of financial reports and market conditions is essential.

*   **Recommendation:** Given the high expected return and strong buy signal, NTRA may be suitable for investors with a high-risk tolerance and a long-term investment horizon. However, caution is advised due to the overbought RSI and the need for continuous monitoring of financial performance and market conditions.

In conclusion, NTRA exhibits high growth potential, but investors should be aware of the inherent risks and volatility associated with the stock.
